Solesence Inc. (SLSN) is a Package Goods/Cosmetics company listed on NASDAQ. In the last 30 days Quantisnow tracked 2 wire items for SLSN, including 1 earnings update and 1 13D/G filing. The most recent was published Nov 9, 2026.
Financial highlights
Full financials- Revenue, TTM
- $55.37M
- Revenue growth
- -14.0%
- Net income, TTM
- -$2.08M
- Net margin
- -3.8%
- Cash
- $1.05M
For the twelve months ended Jun 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks150%
2026-05-172026-11-08
Mix990d
- SEC Filings5(56%)
- Earnings2(22%)
- Other1(11%)
- 13D/G1(11%)
Activity · 52 weeks3328 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- 13D/GAmendment: SEC Form SCHEDULE 13D/A filed by Solesence Inc.SCHEDULE 13D/A - SOLESENCE, INC. (0000883107) (Subject)
- PRSolésence To Report Third Quarter 2026 Financial Results and Host a Conference Call on November 12ROMEOVILLE, Ill., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the third quarter of 2026 after market close on Thursday, November 12, 2026, and host a conference call and webcast on the same date. Third Quarter 2026 Conference Call DetailsDate/Time: Thursday, November 12, 2026 – 4:00 p.m. CT, 5:00 p.m. ET Speakers: Kevin Cureton, President & Chief Executive Officer and Laura Riffner, Chief Financial Officer Webcast Link: https://edge.media-server.com/mmc/p/ym5i5dttDial-In Link: https://register-conf.media-server.c
- SECSEC Form 8-K filed by Solesence Inc.8-K - SOLESENCE, INC. (0000883107) (Filer)
- SECSolesence Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - SOLESENCE, INC. (0000883107) (Filer)
- SECSolesence Inc. filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial Statements and Exhibits8-K - SOLESENCE, INC. (0000883107) (Filer)
- SECSolesence Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SOLESENCE, INC. (0000883107) (Filer)
- PRSolésence Reports Second Quarter 2026 Financial ResultsQuarterly Report Filed on Form 10-Q Company to Host Conference Call at 5:00 p.m. ET Today ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically driven health care solutions across beauty and life science categories, today reported its financial results for the second quarter ended June 30, 2026. "In the second quarter, our business focused on operational execution and financial discipline as we continue implementing our Transform and Transcend strategy," said Kevin Cureton, President and Chief Executive Officer. "By leveraging our intellectual property to enter high-growth markets, and expanding our co-marketing initiatives, we are
- SECSEC Form 10-Q filed by Solesence Inc.10-Q - SOLESENCE, INC. (0000883107) (Filer)
- SECSEC Form NT 10-Q filed by Solesence Inc.NT 10-Q - SOLESENCE, INC. (0000883107) (Filer)
- PRSolésence Reschedules Second Quarter 2026 Conference Call to August 19ROMEOVILLE, Ill., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company has rescheduled its second quarter 2026 conference call and webcast. The additional time will allow the Company to complete its quarterly financial reporting and review process. The conference call and webcast will occur on Wednesday, August 19, 2026, at 5:00 p.m. ET. Second Quarter 2026 Conference Call DetailsDate/Time: Wednesday, August 19, 2026 – 4:00 p.m. CT, 5:00 p.m. ET Speakers: Kevin Cureton, President & Chief Executive Officer and Laura Riffner, Chief Financial Office
- PRSolésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the second quarter of 2026 before the market opens on Tuesday, August 11, 2026, and host a conference call and webcast on the same date. Second Quarter 2026 Conference Call DetailsDate/Time: Tuesday, August 11, 2026 – 7:30 a.m. CT, 8:30 a.m. ET Speakers: Kevin Cureton, President & Chief Executive Officer and Laura Riffner, Chief Financial Officer Webcast Link: https://edge.media-server.com/mmc/p/ecgoveo8/ Dial-In Link: https://register-conf.media-serv
- PRSolésence Brings Patent-Backed Skin Health Innovation to Hair and ScalpNew White Label Collection, Powered by WHSPR™ and Kleair™, Debuts with Revitalizing Scalp Serum and Scalp Screen Dry Shampoo SPF 45+ Sunscreen Scalp Screen Dry Shampoo SPF 45+ Sunscreen Named a Finalist for the 2026 Cosmopack Award for Best Formulation at Cosmoprof Las Vegas ROMEOVILLE, Ill., July 13, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced the launch of two new market-ready products: Revitalizing Scalp Serum and Scalp Screen Dry Shampoo SPF 45+ Sunscreen. Both products are available to brand partners globally and represent a significant expansion into the fa
- SECSolesence Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - SOLESENCE, INC. (0000883107) (Filer)
- PRSolésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation AwardsGlobal Award Recognizes Excellence in Service, Reliability, and Innovation ROMEOVILLE, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, has been named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards. Presented by HPCi Media, the Cosmetics Business Innovation Awards recognize and celebrate the most important innovations driving progress across the global cosmetics and personal care supply chain. The B2B-focused awards program spotlights the very best in ingredients, packaging, contract manufacturing, technology, testing, regula
- PRSolésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of RecognitionSPF-Infused Concealer Featuring Kleair™, WHSPR™, and Chromalüm™ Recognized Across Anti-Aging, Color Cosmetics, and Compromised Skin ROMEOVILLE, Ill., May 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that its prototype product, Day Mode Hero Concealer SPF 50+, has won across three prototype product/chassis categories at the 2026 Cosmetics & Toiletries (C&T) Allē Awards: Anti-Aging, Color Cosmetics, and Compromised Skin. These awards mark Solésence's fourth year of recognition at the Allē Awards since 2022. Day Mode Hero Concealer SPF 50+ leverages three p
- PRSolésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety CoalitionThe report, led by the United Kingdom's APPG for Beauty, Hair & Wellbeing, calls for a national strategy to combat UV exposure, including Government support to enable access to adequate protection, build public awareness and combat misinformation. From left the photo includes: Carolyn Harris, MP, Chair of the APPG for Beauty, Hair & Wellbeing, Victoria Brownlie MBE, Chief Policy & Sustainability Officer, British Beauty Council, Emma Harper, Executive Director, Strategy, Marketing, and Communications, Solésence, Jacqui Burchell, Chief Commercial Officer (CCO), British Beauty Council. ROMEOVILLE, Ill., May 14, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN) a leader in scientifica
- SECSEC Form 10-Q filed by Solesence Inc.10-Q - SOLESENCE, INC. (0000883107) (Filer)
- SECSolesence Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SOLESENCE, INC. (0000883107) (Filer)
- PRSolésence Reports First Quarter 2026 Financial ResultsAdvances implementation of Transform and Transcend strategic initiative across Operational Excellence and New Technology Commercialization ROMEOVILLE, Ill., May 12, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2026. "In March, we introduced Transform and Transcend to our investor community, the strategic initiative that we began at the end of 2025," commented Kevin Cureton, President and Chief Executive Officer. "Our first quarter results reflect our disciplined execution on this initiative, particularly on o
- PRSolésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™New platform technologies enable OTC-grade sensitive skin claims in previously inaccessible anhydrous formats and bring environmental protection deeper into the color cosmetics assortment ROMEOVILLE, Ill., May 11, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced the commercial availability of two proprietary platform technologies: WHSPR™ and Chromalüm™. Both technology platforms are available through finished goods for brand partners globally, and represent a significant expansion of the Company's ingredient technology portfolio. The launch of WHSPR™ and Chromalüm™ adv
- SECSolesence Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - SOLESENCE, INC. (0000883107) (Filer)
- PRSolésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12ROMEOVILLE, Ill., April 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the first quarter of 2026 after the market opens on Tuesday, May 12, 2026, and host a conference call and webcast on the same date. First Quarter 2026 Conference Call DetailsDate/Time: Tuesday, May 12, 2026 – 7:30 a.m. CT, 8:30 a.m. ET Speakers: Kevin Cureton, President & Chief Executive Officer and Laura Riffner, Chief Financial Officer Webcast Link: https://edge.media-server.com/mmc/p/t9uyyvcs Dial-In Link: https://register-conf.media-server.com/re
- PRSolésence, Inc. Announces Appointment of New Independent DirectorMarc James to Join Board of Directors and Serve on Audit, Compensation, and Nominating Committees ROMEOVILLE, Ill., April 27, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced the appointment of Marc James to its Board of Directors as an independent director, effective immediately. James will also serve as a member of the Company's Audit Committee, Compensation Committee, and Nominating Committee. The appointment reflects Solésence's continued focus on maintaining its strong corporate governance and enhancing board expertise as the Company advances its Transform & Tran
- SECAmendment: SEC Form 10-K/A filed by Solesence Inc.10-K/A - SOLESENCE, INC. (0000883107) (Filer)
- SECSEC Form 10-K filed by Solesence Inc.10-K - SOLESENCE, INC. (0000883107) (Filer)
SLSN FAQ
8 questionsWhat is the latest news on SLSN?
In the last 30 days Quantisnow tracked 2 wire items for SLSN: 1 earnings update and 1 13D/G filing. The most recent was published on November 9, 2026.What is SLSN revenue?
Solesence Inc. (SLSN) reported $55.37M of revenue for the twelve months ended Jun 30, 2026. That is down 14.0% from the year before. Revenue for fiscal 2025 was $62.06M.Is SLSN profitable?
No. Solesence Inc. reported a net loss of $2.08M for the twelve months ended Jun 30, 2026.How much cash and debt does SLSN have?
Solesence Inc. reported $1.05M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does SLSN stock trade?
Solesence Inc. (SLSN) is listed on NASDAQ.What sector and industry is SLSN in?
Solesence Inc. operates in the Consumer Discretionary sector, Package Goods/Cosmetics industry.What companies are similar to SLSN?
Notable peers in the same industry include PG (Procter & Gamble Company), KVUE (Kenvue Inc.), HLN (Haleon plc), EL (Estee Lauder Companies Inc.), CHD (Church & Dwight Company Inc.). Compare SLSN side-by-side with any of them on Quantisnow.How can I track SLSN on Quantisnow?
Quantisnow aggregates Solesence Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SLSN to receive live email and push alerts on every new disclosure.